Autori: Van Cutsem Eric
| Naslov | Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer (Article) |
| Autori | Van Cutsem Eric Hidalgo Manuel Canon Jean-Luc Macarulla Teresa Bazin Igor Poddubskaya Elena Manojlovic Nebojsa S Radenkovic Dejan V Verslype Chris Eric Raymond Cubillo Antonio Schueler Armin Zhao Charles Hammel Pascal |
| Info | INTERNATIONAL JOURNAL OF CANCER, (2018), vol. 143 br. 8, str. 2053-2064 |
| Projekat | Merck KGaA, Darmstadt, Germany [NCT01016483]; EMD Serono, Inc. [NCT01016483] |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer. (Meeting Abstract) |
| Autori | Van Cutsem Eric Hidalgo Manuel Bazin Igor Canon Jean-Luc Poddubskaya Elena Manojlovic Nebojsa S Milella Michele Radenkovic Dejan V Verslype Chris Guo Wei Damstrup Lars Hammel Pascal |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2015), vol. 33 br. 3, Suppl. S, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
